Trends in Incidence of Urinary Tract Infection in Mainland China from 1990 to 2019.
age–period–cohort analysis
bacterial infection
urinary tract infection
Journal
International journal of general medicine
ISSN: 1178-7074
Titre abrégé: Int J Gen Med
Pays: New Zealand
ID NLM: 101515487
Informations de publication
Date de publication:
2021
2021
Historique:
received:
10
02
2021
accepted:
22
03
2021
entrez:
28
4
2021
pubmed:
29
4
2021
medline:
29
4
2021
Statut:
epublish
Résumé
Urinary tract infection (UTI) is the second-most-common type of infection in China. This study aimed to determine the long-term trends in the incidence of UTI in Mainland China between 1990 and 2019. Data were extracted from the Global Burden of Disease Study 2019 and were analyzed with the age-period-cohort framework. The net drift in the incidence of UTI was -0.37% (95% CI: -0.40%, -0.35%) in males and -0.25% (95% CI: -0.29%, -0.20%) in females. For males, the local drift was lower than 0 (P<0.05) among those younger than 90 years. For females, the local drift was lower than 0 (P<0.05) among those younger than 60 years and higher than 0 (P<0.05) in those aged 65-79 years. In the same birth cohort, the incidence of UTI was higher in females than in males in all age groups (P<0.05). The period relative risk (RR) showed a decreasing pattern after 2005 in both sexes. The cohort RR showed a downward trend of the birth cohort after 1905 for males and 1960 for females. The incidence has increased significantly among older females over the past 30 years. It is necessary to develop a comprehensive intervention plan for reproductive health services covering females and males of all ages.
Identifiants
pubmed: 33907445
doi: 10.2147/IJGM.S305358
pii: 305358
pmc: PMC8068484
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1413-1420Informations de copyright
© 2021 Yuan et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
J Urol. 2005 Apr;173(4):1281-7
pubmed: 15758783
Lancet. 2019 Sep 28;394(10204):1145-1158
pubmed: 31248666
Protein Cell. 2015 May;6(5):314-21
pubmed: 25779341
Protein Cell. 2019 Jul;10(7):476-484
pubmed: 30937856
PLoS One. 2018 Jan 5;13(1):e0190521
pubmed: 29304056
N Engl J Med. 2016 Jun 2;374(22):2192
pubmed: 27248641
Infect Control Hosp Epidemiol. 2018 Jun;39(6):701-709
pubmed: 29655388
Menopause. 2015 May;22(5):505-11
pubmed: 25349959
Clin Drug Investig. 2013 Apr;33(4):255-61
pubmed: 23475540
Proc Natl Acad Sci U S A. 2015 Feb 24;112(8):E871-80
pubmed: 25675528
Infect Dis Ther. 2014 Dec 18;:
pubmed: 25519161
J Pediatr (Rio J). 2015 Nov-Dec;91(6 Suppl 1):S2-10
pubmed: 26361319
Nat Rev Microbiol. 2015 May;13(5):269-84
pubmed: 25853778
Future Microbiol. 2017 Mar;12:239-246
pubmed: 28262045
Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2296-302
pubmed: 25146089
Int J Environ Res Public Health. 2018 Jan 22;15(1):
pubmed: 29361804
Am J Med Sci. 1997 Oct;314(4):245-9
pubmed: 9332263
N Engl J Med. 1993 Sep 9;329(11):753-6
pubmed: 8350884
Ann Intern Med. 2017 Oct 3;167(7):ITC49-ITC64
pubmed: 28973215
J Urol. 2005 Apr;173(4):1288-94
pubmed: 15758784
Glob Public Health. 2015;10(2):249-51
pubmed: 25515316
Eur Urol Focus. 2017 Apr;3(2-3):207-211
pubmed: 28965960
Trends Mol Med. 2016 Nov;22(11):946-957
pubmed: 27692880
Ann Pharmacother. 2004 Oct;38(10):1692-701
pubmed: 15340129
PLoS One. 2019 Apr 11;14(4):e0212772
pubmed: 30973941
Am J Kidney Dis. 2004 Aug;44(2):353-62
pubmed: 15264195
Singapore Med J. 2016 Sep;57(9):485-90
pubmed: 27662890
Comput Biol Med. 2016 Mar 1;70:12-22
pubmed: 26780249
Expert Rev Pharmacoecon Outcomes Res. 2005 Aug;5(4):457-66
pubmed: 19807263
J Huazhong Univ Sci Technolog Med Sci. 2004;24(3):303-4
pubmed: 15315357
Nat Rev Urol. 2010 Dec;7(12):653-60
pubmed: 21139641
Int J Equity Health. 2014 Jan 02;13:1
pubmed: 24383432
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326